Advanced Search

Therapeutic Goods (Listing) Notice 2009 (No. 6)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
 
Therapeutic Goods Act 1989
 
Therapeutic Goods (Listing) Notice 2009 (No. 6)
 
I, ROHAN HAMMETT, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the ARTG) for listed goods:
·           preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990 (the Regulations) that contain Chlorella vulgaris as a therapeutically active ingredient in listed medicines. subject to the following conditions:
-              that such preparations are for oral use only; and
-              the recommended daily dose must contain less than 300 micrograms of iodine.
 
This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.
 
Pursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the ARTG for listed goods.
 
 
 
Dated this      8th    day of October 2009
 
 
(signed by)
 
Dr Rohan Hammett
Delegate of the Minister for Health and Ageing